Clinical Trials Logo

Abnormal Uterine Bleeding clinical trials

View clinical trials related to Abnormal Uterine Bleeding.

Filter by:

NCT ID: NCT03697733 Not yet recruiting - Clinical trials for Abnormal Uterine Bleeding

Comparison Efficiency of Oral Etoricoxib Versus Intravenous Fentanyl on Post Operative Pain in Curettage Under TIVA

Start date: November 1, 2018
Phase: N/A
Study type: Interventional

Comparison of the efficiency of oral Etoricoxib versus intravenous Fentanyl on post operative Pain in curettage under TIVA: A randomized controlled trial

NCT ID: NCT03638856 Not yet recruiting - Infertility, Female Clinical Trials

Comparing Effectiveness of Oral Misoprostal for Cervical Priming in Hysteroscopy

Start date: September 30, 2018
Phase: N/A
Study type: Interventional

Research objective To compare effectiveness of oral Misoprostal for cervical priming in premenopausal women underwent to diagnostic hysteroscopy Research hypothesis: Null hypothesis Effectiveness of oral misoprostal for cervical priming in premenopausal women underwent to diagnostic hysteroscopy is not different from placebo Alternative hypothesis: : Oral Misoprostal for cervical priming in Premenopausal women underwent to diagnostic hysteroscopy is better than placebo

NCT ID: NCT03441087 Completed - Clinical trials for Abnormal Uterine Bleeding

The Role of TVSG and HS in Determining Endometrial Pathologies

Start date: January 1, 2011
Phase: N/A
Study type: Interventional

Although hysteroscopy (HS) and transvaginal ultrasonography (TVSG) are methods in the diagnosis of AUB, there is some suspicion about their efficacy. The aim of this study was to determine the efficacy and safety of HS and TVSG on diagnosing abnormal uterine bleeding(AUB) .216 women admitted to the investigators clinic (Sisli Ethal Training and Research Hospital, Obstetrics and Gynecology Department Obstetrics Service ) between 21-51 years of age. These patients were divided into two groups; menopause (71women) and pre-menopause (145 women). HS and endometrial sampling were performed both groups after TVSG.The success of these methods was assessed by kappa analysis

NCT ID: NCT03428854 Not yet recruiting - Adenomyosis Clinical Trials

Adenomyosis: Genomic Mechanisms and Biological Response

Start date: September 1, 2018
Phase: N/A
Study type: Observational

Examination of genomic and biologic responses to LNG-IUS in patients with adenomyosis.

NCT ID: NCT03130387 Completed - Clinical trials for Abnormal Uterine Bleeding

Prevalence of Cesarean Section Niche in Women With Unexplained Abnormal Uterine Bleeding

Niche
Start date: January 1, 2016
Phase: N/A
Study type: Interventional

Prevalence of Cesarean Section Niche in women With Unexplained Abnormal Uterine Bleeding

NCT ID: NCT02192606 Completed - Uterine Fibroids Clinical Trials

Does 3D Laparoscopy Improve Vaginal Cuff Suture Time?

3DRCT
Start date: November 2013
Phase: N/A
Study type: Interventional

The objective aim is to evaluate whether the use of 3D laparoscopy facilitates the vaginal cuff closure of the vaginal cuff during a total laparoscopic hysterectomy among novice laparoscopists (PGY 2-4, Fellow). This is a randomized single blinded controlled trial comparing the difference in 2D vs. 3D in regards to vaginal cuff closure time stratified by residents and fellows. Patients will undergo a total laparoscopic hysterectomy and will be randomized to either 2D versus 3D.

NCT ID: NCT02029144 Completed - Clinical trials for Abnormal Uterine Bleeding

Observational Study of Dydrogesterone in Cycle Regularization

Start date: December 2013
Phase: N/A
Study type: Observational

Dydrogesterone has been widely used worldwide for various gynecological and obstetric indications: - Dydrogesterone is effective in cycle regulation treatment. - Dydrogesterone is recognized as none interference to hypothalamus pituitary ovary (HPO) axis in the recommended dosage. - Dydrogesterone might have non-negative effect on glucose and lipid metabolic.

NCT ID: NCT02002260 Recruiting - Clinical trials for Abnormal Uterine Bleeding

Stopping Heavy Periods Project

SHiPP
Start date: February 2013
Phase: N/A
Study type: Interventional

This study is a randomized clinical trial comparing the levonorgestrel intrauterine system (LNG-IUS) to combined oral contraceptives (COCs) for treatment of heavy menstrual bleeding. This study is designed to be conducted within the context of a patient's standard/usual/typical care from their primary gynecologic care provider. We hypothesize that, compared to COCs, the LNG-IUS will be more effective at improving bleeding-related quality of life and will be associated with fewer treatment failures and greater cost-effectiveness at one year. To test these hypotheses, we plan to enroll 59 women from several sites who present for gynecologic care and self-report heavy menstrual bleeding into a RCT comparing LNG-IUS to COCs. The eligible study population includes women with heavy menstrual bleeding secondary to ovulatory disorders (AUB-O) or endometrial hemostatic disorders (AUB-E). Women meeting study eligibility will be randomized to receive LNG-IUS or COCs. Main study outcomes will be obtained at 6 weeks, 3 months, 6 months, and 1 year.

NCT ID: NCT01908738 Completed - Clinical trials for Abnormal Uterine Bleeding

Effectiveness of Paracervical Block Versus Lidocaine Spray During Endometrial Biopsy

Start date: September 2013
Phase: N/A
Study type: Interventional

The purpose of this study to determine effectiveness of paracervical block, lidocaine spray and only oral analgesic drugs for pain relief during endometrial biopsy.

NCT ID: NCT01786798 Recruiting - Clinical trials for Abnormal Uterine Bleeding

Transvaginal Ultrasound in Women With Abnormal Uterine Bleeding

Start date: February 2013
Phase: N/A
Study type: Interventional

The objective of this study is to investigate the role of transvaginal ultrasound in detecting endometrial hyperplasia and endometrial cancer in women aged more than 35 presenting with abnormal uterine bleeding.